This proposal describes the development of a Genetics Research Center (GRC) at the University of Chicago to be part of a cooperative Inflammatory Bowel Disease (IBD) Genetics Consortium. The GRC will serve the dual functions of a) proposing and performing approved studies which will make optimal use of Consortium resources and strengths, (Specific Aims I and II), and, b) recruiting appropriate patients as defined by the Consortium Steering Committee, as well as appropriately phenotyping patients using criteria commonly agreed to by the Consortium (Specific Aim III). We have recently established that three polymorphisms within Nod2 are highly associated with susceptibility to familial Crohn's disease (CD). While the signaling partners and ligands of Nod2 are incompletely defined at present, it is known that RICK/RIP2/CARDIAK, a serine-threonine kinase which binds Nod2, is recruited to the TNFR1 complex, as well as to other members of the TNFR superfamily such as Fas and CD40. Because Nod2 polymorphisms are neither necessary nor sufficient for CD expression, we hypothesize that additional genes increasing susceptibility to CD can be identified either through stratifying linkage analyses based on Nod2 genotypes (specific aim I) or through consideration of candidate genes involved in signaling pathways involving Nod2 (specific aim II).
Specific Aim I : To identify the CD susceptibility gene on chromosome 16p which positively interacts with Nod2 to increase disease risk. Redefining as """"""""affected"""""""" only the subset of CD individuals carrying the major Nod2 risk alleles, we demonstrate evidence for linkage in the chromosome 16p region independent of the contribution from Nod2 on chromosome 16q12. The identification of genes positively interacting with Nod2 will provide critical insight into disease pathogenesis.
Specific Aim II. To utilize information from a stratified Consortium linkage analysis to prioritize and test genes in the signaling pathway involving Nod2 for association to CD. Increased priority is given to those genes involved in both Nod2 and TNF signaling pathways, such as RICK/RIP2/CARDIAK. III. To develop a Clinical Core which will be responsible for additional patient recruitment and phenotyping as mandated by the Consortium Steering and Planning Committee. To collect additional African-American patients with CD. Preliminary data demonstrate that comparative studies in African-Americans will provide important insight into disease pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
7U01DK062422-06
Application #
7430258
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (M1))
Program Officer
Karp, Robert W
Project Start
2002-09-30
Project End
2007-08-31
Budget Start
2006-07-01
Budget End
2007-08-31
Support Year
6
Fiscal Year
2006
Total Cost
$307,205
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Hinks, Anne; Marion, Miranda C; Cobb, Joanna et al. (2018) Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. Arthritis Rheumatol 70:957-962
Hui, Ken Y; Fernandez-Hernandez, Heriberto; Hu, Jianzhong et al. (2018) Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Sci Transl Med 10:
Misra, Ravi; Arebi, Naila (2017) Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology 152:2082-2083
Yan, Jie; Hedl, Matija; Abraham, Clara (2017) An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes. J Clin Invest 127:2192-2205
Lahiri, Amit; Hedl, Matija; Yan, Jie et al. (2017) Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes. Nat Commun 8:15614
Huang, Hailiang; Fang, Ming; Jostins, Luke et al. (2017) Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547:173-178
Hinks, A; Bowes, J; Cobb, J et al. (2017) Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Ann Rheum Dis 76:765-772
Yadav, Pankaj; Ellinghaus, David; Rémy, Gaëlle et al. (2017) Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice. Gastroenterology 153:550-565
Cummings, Ryan J; Barbet, Gaetan; Bongers, Gerold et al. (2016) Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature 539:565-569
Rivas, Manuel A; Graham, Daniel; Sulem, Patrick et al. (2016) A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat Commun 7:12342

Showing the most recent 10 out of 85 publications